ABBOTT LABORATORIES (ABT) Stock Fundamental Analysis
USA • New York Stock Exchange • NYSE:ABT • US0028241000
113.59 USD
+1.31 (+1.17%)
At close: Feb 11, 2026
113.59 USD
0 (0%)
After Hours: 2/11/2026, 6:05:21 PM
We assign a fundamental rating of 6 out of 10 to ABT. ABT was compared to 186 industry peers in the Health Care Equipment & Supplies industry. ABT scores excellent on profitability, but there are some minor concerns on its financial health. ABT is not valued too expensively and it also shows a decent growth rate. ABT also has an excellent dividend rating. These ratings could make ABT a good candidate for dividend investing.
1. Profitability
1.1 Basic Checks
- ABT had positive earnings in the past year.
- In the past year ABT had a positive cash flow from operations.
- In the past 5 years ABT has always been profitable.
- ABT had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- ABT's Return On Assets of 16.60% is amongst the best of the industry. ABT outperforms 97.31% of its industry peers.
- ABT has a better Return On Equity (27.43%) than 98.39% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 8.88%, ABT belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 31.88%, ABT belongs to the top of the industry, outperforming 98.39% of the companies in the same industry.
- In the last couple of years the Profit Margin of ABT has grown nicely.
- The Operating Margin of ABT (18.29%) is better than 89.78% of its industry peers.
- In the last couple of years the Operating Margin of ABT has grown nicely.
- ABT has a Gross Margin (56.19%) which is in line with its industry peers.
- In the last couple of years the Gross Margin of ABT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
2. Health
2.1 Basic Checks
- ABT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- There is no outstanding debt for ABT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
- An Altman-Z score of 5.32 indicates that ABT is not in any danger for bankruptcy at the moment.
- ABT has a better Altman-Z score (5.32) than 79.03% of its industry peers.
- The Debt to FCF ratio of ABT is 1.87, which is an excellent value as it means it would take ABT, only 1.87 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 1.87, ABT belongs to the best of the industry, outperforming 88.17% of the companies in the same industry.
- ABT has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- With a Debt to Equity ratio value of 0.23, ABT perfoms like the industry average, outperforming 56.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.32 |
ROIC/WACC0.91
WACC9.73%
2.3 Liquidity
- ABT has a Current Ratio of 1.70. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.70, ABT is not doing good in the industry: 68.28% of the companies in the same industry are doing better.
- ABT has a Quick Ratio of 1.24. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ABT (1.24) is worse than 65.05% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 10.28% over the past year.
- The Earnings Per Share has been growing slightly by 7.13% on average over the past years.
- Looking at the last year, ABT shows a small growth in Revenue. The Revenue has grown by 5.67% in the last year.
- ABT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- The Earnings Per Share is expected to grow by 10.18% on average over the next years. This is quite good.
- The Revenue is expected to grow by 7.15% on average over the next years.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.18%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.15%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 22.06, ABT is valued on the expensive side.
- ABT's Price/Earnings ratio is rather cheap when compared to the industry. ABT is cheaper than 82.26% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 28.23, ABT is valued a bit cheaper.
- With a Price/Forward Earnings ratio of 19.78, ABT is valued on the expensive side.
- ABT's Price/Forward Earnings ratio is rather cheap when compared to the industry. ABT is cheaper than 82.80% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of ABT to the average of the S&P500 Index (28.01), we can say ABT is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.06 | ||
| Fwd PE | 19.78 |
4.2 Price Multiples
- 78.49% of the companies in the same industry are more expensive than ABT, based on the Enterprise Value to EBITDA ratio.
- Based on the Price/Free Cash Flow ratio, ABT is valued cheaply inside the industry as 81.18% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 28.56 | ||
| EV/EBITDA | 17.95 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- The decent profitability rating of ABT may justify a higher PE ratio.
PEG (NY)1.92
PEG (5Y)3.09
EPS Next 2Y10.76%
EPS Next 3Y10.33%
5. Dividend
5.1 Amount
- ABT has a Yearly Dividend Yield of 2.31%. Purely for dividend investing, there may be better candidates out there.
- ABT's Dividend Yield is rather good when compared to the industry average which is at 0.20. ABT pays more dividend than 97.85% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.79, ABT pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.31% |
5.2 History
- On average, the dividend of ABT grows each year by 11.40%, which is quite nice.
- ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
- ABT has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
5.3 Sustainability
- 28.93% of the earnings are spent on dividend by ABT. This is a low number and sustainable payout ratio.
- The dividend of ABT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
113.59
+1.31 (+1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.33%
Inst Owner Change-1.33%
Ins Owners0.45%
Ins Owner Change0.04%
Market Cap197.52B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts79.43
Price Target136.02 (19.75%)
Short Float %1.15%
Short Ratio2.28
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.31% |
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-15 2026-01-15 (0.63)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-7.35%
PT rev (3m)-7.37%
EPS NQ rev (1m)-0.04%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.16%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.88%
Revenue NY rev (3m)-0.63%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 22.06 | ||
| Fwd PE | 19.78 | ||
| P/S | 4.51 | ||
| P/FCF | 28.56 | ||
| P/OCF | 21.66 | ||
| P/B | 3.88 | ||
| P/tB | 9.24 | ||
| EV/EBITDA | 17.95 |
EPS(TTM)5.15
EY4.53%
EPS(NY)5.74
Fwd EY5.06%
FCF(TTM)3.98
FCFY3.5%
OCF(TTM)5.24
OCFY4.62%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)1.92
PEG (5Y)3.09
Graham Number58.27
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.32 |
F-Score8
WACC9.73%
ROIC/WACC0.91
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.18%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.2%
Revenue Next 3Y7.11%
Revenue Next 5Y7.15%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.17%
EBIT Next 3Y13.91%
EBIT Next 5Y14.39%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A
ABBOTT LABORATORIES / ABT FAQ
What is the fundamental rating for ABT stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABT.
What is the valuation status of ABBOTT LABORATORIES (ABT) stock?
ChartMill assigns a valuation rating of 5 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
What is the profitability of ABT stock?
ABBOTT LABORATORIES (ABT) has a profitability rating of 7 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 22.06 and the Price/Book (PB) ratio is 3.88.
Can you provide the expected EPS growth for ABT stock?
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.5% in the next year.